Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
274 hedge funds and large institutions have $1.62B invested in Avanos Medical in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 80 increasing their positions, 68 reducing their positions, and 43 closing their positions.
39,957% more call options, than puts
Call options by funds: $2.8M | Put options by funds: $7K
18% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 68
0.55% more ownership
Funds ownership: 91.83% → 92.38% (+0.55%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 291 → 274 (-17)
16% less capital invested
Capital invested by funds: $1.93B → $1.62B (-$315M)
40% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 43
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$72.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.3M |
| 3 |
D.E. Shaw & Co
New York
|
+$13.2M |
| 4 |
Morgan Stanley
New York
|
+$11.1M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
+$10.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$80M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$30.8M |
| 3 |
CIM
Confluence Investment Management
St. Louis,
Missouri
|
-$20.4M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$12.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.61M |
AVNS Hedge Fund Activity: Q2 2021 in Review
274 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q2 2021, worth a combined $1.62B — down 16% from $1.93B a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of AVNS and 26 opened new positions — a net loss of 17 holders — while 68 trimmed existing stakes and 80 added.
The largest buyer was BlackRock, adding an estimated $72.8M. The largest seller was Victory Capital Management, cutting an estimated $80M.
- 274 institutional investors held Avanos Medical (AVNS) as of Q2 2021, down from 291 in Q1 2021.
- Funds reported $1.62B of Avanos Medical stock for Q2 2021, down 16% quarter-over-quarter.
- 26 funds opened new Avanos Medical positions in Q2 2021 and 43 closed out, a net change of -17 holders.
- The largest Avanos Medical buyer in Q2 2021 was BlackRock, an estimated $72.8M added.
- The largest Avanos Medical seller in Q2 2021 was Victory Capital Management, an estimated $80M sold.
Based on aggregated 13F filings for Q2 2021.